Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-Analysis.
Saved in:
| Title: | Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-Analysis. |
|---|---|
| Authors: | Wu P; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Gu X; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Li D; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Zi X; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Shang D; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Liu J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Ma R; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Peng J; Department of Otolaryngology-Head and Neck Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou China., Zhang G; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Che Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Zeng Q; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Zhao B; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Sun N; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., Zhang C; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China., He J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center For Cancer/ Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. |
| Source: | MedComm [MedComm (2020)] 2026 Feb 09; Vol. 7 (2), pp. e70624. Date of Electronic Publication: 2026 Feb 09 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2688-2663 |
|---|---|
| DOI: | 10.1002/mco2.70624 |
